VNI is a CYP51 inhibitor, which inhibits the production of sterol used in the biosynthesis of membranes. The metabolic pathway of CYP51 can ultimately lead to membrane assembly in pathogens, membrane assembly in proliferating tumor cells and is a target for clinical and agricultural antifungals.
您的位置：
